Drug
YM 529 clinical trials
Also written ONO-5920 and Minodronic acid.
How studies write it
Studies that test it under each name
Other names
Studies by the year they started
7 studies that test it; most in 2002 (1)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2014 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 2
Astellas Pharma Inc (2) · Ono Pharmaceutical Co. Ltd (2) · Wuhan Union Hospital, China (1) · Ono Pharmaceutical Co., Ltd. (1) · Peking University Third Hospital (1)
Studies
Open first, then newest update. How each study uses YM 529 is read from its arms, and is right about nine times in ten.
Testing it · 7
- Efficacy and Safety of Minodronate in Patients With Low Back PainStatus unknownPhase 4Peking University Third HospitalNCT05645289Written as Minodronate
- ONO-5920/YM529 Confirmatory Study in Involutional Osteoporosis PatientsCompletedPhase 2/3Astellas Pharma IncNCT00794443Written as YM529 / ONO-5920
- Pharmacokinetics and Tolerability of Minodronic Acid and Food and Age Effects on the PharmacokineticsCompletedPhase 1Wuhan Union Hospital, ChinaNCT02295436Written as minodronic acid
- Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in JapanCompletedPhase 3Ono Pharmaceutical Co. LtdNCT00212667Written as ONO-5920
- Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in JapanCompletedPhase 3Ono Pharmaceutical Co. LtdNCT00212719Written as ONO-5920
- Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in JapanCompletedPhase 3Ono Pharmaceutical Co., Ltd.NCT00212628Written as Minodronic acid hydrate
- A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent FormulationCompletedPhase 1Astellas Pharma IncNCT00965978Written as ONO-5920 / YM529
Codes
What other systems call YM 529 · ClinicalTrials.gg INT003792
Also registered as minodronic acid (UNII 40SGR63TGL) and minodronic acid monohydrate (UNII 457X74V7ND).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.